This video is a great explainer on how CBD helps people. Stress, anxiety and PTSD shouldnt be taken lightly. Stress can add years to someones appearance because it take a lot of energy out of you to fight it. Anxiety and PTSD are stress related. You build up anxiety during stressful situations. PTSD is direct traumatic experiences from stressful situations that leave everlasting scares that may never heal. CBD isnt the cure. CBD help people who are stress, have high anxiety, or who have come out of traumatic situations and are left with scary scars for life. Check the video out.
WHAT DOES THE FARM BILL DO?
ANALYSIS BY U.S. HEMP ROUNDTABLE GENERAL COUNSEL JONATHAN MILLER
Late in the evening of December 10, 2018, the 2018 Farm Bill House/Senate Conference Committee
released its Conference Report. The 807-page document is nearly half a foot tall. Hemp is discussed in
only a few handfuls of pages. But the impact on the industry is monumental:
• The era of hemp prohibition is over. Hemp is now permanently removed from the Controlled
Substances Act (CSA). It is forever deemed an agricultural commodity, no longer mistaken as a
controlled substance, like marijuana.
• By redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly has
removed popular hemp products — such as hemp-derived cannabidiol (CBD) — from the purview of
the CSA. Accordingly, the Drug Enforcement Administration no longer has any possible claim to
interfere with the interstate commerce of hemp products. This should give comfort to federally
regulated institutions — banks, merchant services, credit card companies, e-commerce sites and
advertising platforms — to conduct commerce with the hemp and hemp product industry.
• Hemp farmers now may finally access needed crop insurance and can fully participate in USDA
programs for certification and competitive grants.
• State and Tribal governments may impose separate restrictions or requirements on hemp growth and
the sale of hemp products – however, they cannot interfere with the interstate transport of hemp or
hemp products. We are hopeful that local and state officials will follow Congress’ lead, as well as the
statements and resolutions of the World Health Organization and the U.S. Food and Drug
Administration (FDA) that declare, after intense scientific scrutiny, that CBD is safe, non-toxic, and
• The FDA continues to exercise jurisdiction over the regulation of ingestible and topical hemp
products. We applaud the agency’s continued efforts to crack down on bad actors who undermine
the industry through misguided marketing claims. And while we are concerned about non-binding
statements made by the FDA that have led some state and local officials to question the legality of
the retail sale of hemp-derived CBD, we are hopeful that we can work with the agency to clarify that
CBD – which their own scientists concluded has no abuse potential and does not pose a risk to public
health – should not be withheld from Americans who count on it for their health and wellness.
SECTION BY SECTION
Section 7129 (p. 313): Includes hemp in USDA’s supplemental and alternative crops programs.
Section 7501 (p. 338): Includes hemp in USDA’s critical agricultural materials programs.
Section 7605 (p. 347): Orders the USDA Secretary to prepare a report on the 2014 Farm Bill pilot
program, and then repeals that program one year after the new permanent hemp program is created.
Section 10113 (p. 429): The guts of the new permanent legalization regime:
• Section 297A (p. 429) Defines hemp as all parts of the plant less than 0.3% THC, including
“derivatives,” “extracts” and “cannabinoids” and permits hemp production in all states and territories.
• Section 297B (a)-(d) (p. 429) Empowers states and Tribes to submit plans to USDA to implement
a permanent hemp growing program. Requires information gathering, testing, inspection and disposal procedures. The USDA Secretary must sign off on, or reject, the plan within 60 days, and consult with the
Attorney General. The Secretary can later audit state programs and work with the states to develop
corrective action plans where there is noncompliance.
• Section 297B(e)(p. 431): Orders states and Tribes to develop procedures to address violations, including
corrective action in the case of negligence.
• Section 297B(e)(3)(B) (p. 432): Individuals who commit drug felonies cannot participate in state or Tribal
growth programs for 10 years following the date of their conviction. However, participants in the 2014 Farm
Bill pilot programs are grandfathered in to participate in permanent programs despite any prior felony
• Section 297C (p. 432): States and Tribes are required to maintain information on lands where hemp is grown
and testing, enforcement, inspection and disposal procedures. The USDA Secretary must collect such
information to be accessible in real time to local, state and federal law enforcement.
• Section 297D (p. 434): The USDA Secretary is required to promulgate guidelines and regulations and submit
an annual report to Congress on the program’s implementation.
• Section 297D(c)(p. 434): Nothing in the new law affects the FDA’s authority under the Food, Drug and
Cosmetic Act or the Public Health Service Act.
Section 10114 (p. 435): Nothing in the act prohibits the interstate commerce of hemp, nor can States or Tribes prohibit
the transportation of hemp or hemp products through their territory.
Title XI (p. 439): Hemp farmers are made eligible for crop insurance, and marketability requirements for the crop
insurance program can be waived.
Section 12619 (p. 540): Hemp is removed from the definition of “marihuana,” and THC found in hemp is excluded from
the definition of a controlled substance.
Key notes from the Conference Report Managers’ Summary:
p. 738: The Managers note that “state and Tribal governments are authorized to put more restrictive parameters on the
production of hemp, but are not authorized to alter the definition of hemp or put in place policies that are less
p. 738: The Managers note that the USDA Secretary must consult with the Attorney General regarding approval of state
or Tribal plans, but “the Managers intend that the final decision to be made by the Secretary.” States or Tribes can
appeal or resubmit plans that are rejected or revoked.
p. 739: Any drug felonies committed after the permanent program begins will ban participants from participating,
regardless of whether they participated in the 2014 Farm Bill pilot program.
p. 739: The USDA Secretary must make program information accessible in real time to law enforcement, and is
encouraged to develop a memorandum of understanding to define the parameters of this information sharing.
p. 739: “While states and Indian tribes may limit the production and sale of hemp and hemp products within their
borders, the Managers, in Section 10122, agreed to not allow such states and Indian tribes to limit the transportation or
shipment of hemp or hemp products through the state or Indian territory.”
WTMJ 4 Milwaukee local news did another story on the benefits of CBD. It is going viral. The benefits are proving to be highly successful in treating multiple things. This is yet more proof that alternative medicine will beat the pharmaceutical companies.
Minutes after taking a small dose of CBD, this man got the relief he needed from his parkinson’s disease. Everyday people with parkinson’s deal with thing us normal people cant imagine. Thanks to CBD, some of these people who suffer are finally getting a naural way to relax. CBD has profound uses. This is just one example of how we benefit from CBD.
Theres plenty of proof that CBD has a tremendous affect on Cancer. Widespread studies have shown that CBD isnt 100% the cure but it effectively reduces the size of Cancer cells. Not only does it reduce the size of cancer cells but it also aids in recovery from cancer treatments. Cancer patients are stuck using pharmaceuticals and left with tons of side affects to deal with. CBD helps them get by.
Spurred by growing reports of the medical efficacy of cannabidiol (CBD), the second leading active ingredient in marijuana, patients are increasingly seeking out high-CBD varieties for treatment of conditions ranging from severe epilepsy and multiple sclerosis to anxiety and cancer pain.
CBD has long been overshadowed by delta-9-THC (tetrahydrocannabinol), the primary active ingredient in marijuana, because unlike THC, it does not produce a psychoactive “high.” CBD has nonetheless long been known to have useful anti-spasmodic, anti-epileptic, anti-anxiety, and anti-psychotic properties.
Although CBD lacks noticeable effects when taken alone, it has a calming, sedative effect when combined with THC, cutting down on the anxiety, paranoia, and memory impairment that many users find unpleasant or debilitating with regular marijuana. CBD-rich strains accordingly have particular appeal to older users and medical patients who are uncomfortable with the THC high.
Public interest in CBD was aroused by a recent CNN report on medical marijuana by Dr. Sanjay Gupta. Previously a skeptic on medical marijuana, Dr. Gupta admitted to having been “brainwashed” by government propaganda. Gupta featured the story of a 5-year-old girl, Charlotte Figi, who suffered continual epileptic seizures from a rare disease known as Dravet’s syndrome. Conventional treatment having failed, Charlotte’s condition dramatically improved after she was treated orally with an extract of CBD-rich cannabis.
In the wake of Gupta’s show, providers of high-CBD strains have been besieged by requests from parents of children with Dravet’s, including from non-medical marijuana states. Utah recently held hearings at the state legislature about drafting a bill on the topic.
Meanwhile, Modesto City Council denied a request by Jason David and other parents to allow them to grow and test their children’s medicine, and David’s son Jayden is no longer allowed to take his medicine at his school.
A survey by Stanford researchers of 19 severely epileptic children found that 84% experienced substantial seizure reductions from CBD-enriched cannabis.
In the U.K., GW Pharmaceuticals has developed a natural cannabis extract known as Sativex, consisting of equal parts CBD and THC. In tests with multiple sclerosis patients, GW researchers found that subjects responded better to equal parts CBD and THC than to either pure THC or CBD. Sativex has been approved in the U.K for treatment of MS, and has shown promise in human subjects for treatment of cancer pain and neuropathic pain.
GW is also developing a pure CBD extract known as Epidiolex, which is undergoing FDA “orphan drug” studies for treatment of pediatric epilepsy.
Additional, preclinical studies suggest that CBD may have therapeutic benefits in the treatment of various conditions, including chronic pain, anxiety, nausea,rheumatoid arthritis, schizophrenia, diabetes, PTSD,alcoholism, strokes and cardiovascular disease, cancer,and other ailments.
CBD has been shown to suppress colon cancer tumors in mice and to kill breast cancer cells in lab studies by Dr. Sean McAllister at the California Pacific Medical Center. However, cancer specialists caution that the efficacy of CBD for cancer remains to be demonstrated in actual human studies.
CBD also has anti-inflammatory, neuro-protective, and anti-oxidant properties. Anti-oxidants are thought to fight degenerative diseases and aging. CBD has also been shown to stimulate bone fracture healing in laboratory animals.
Until recently, CBD-rich marijuana was generally unavailable in the U.S. because breeders had concentrated on developing plants with high THC, breeding out CBD in the process. Fewer than 5% of samples tested show appreciable amounts of CBD. Only with the advent of laboratory testing, first pioneered by Harborside Health Center and Steep Hill Labs in Oakland, did it become possible to detect and breed high-CBD varieties of cannabis, since CBD is otherwise undetectable by appearance or odor.
In response to growing demand, numerous strains of CBD-rich varieties have been developed by breeders in California and elsewhere, although they are still difficult to find in many dispensaries. Consumers are cautioned not to buy CBD-rich varieties unless they have been laboratory tested.
Contrary to popular misconception, so-called indica varieties are no more likely to have CBD than sativas. Lab studies by the WercShop, co-sponsored by California NORML, found no relation between chemical profiles, as measured by cannabinoid and terpene content, and varietal types, whether indica or sativa. Breeders have developed special high-CBD hybrids from various genetic stock. Some have virtually pure CBD, while others typically have THC; CBD ratios ranging from 2:1 to 1:2.
The optimal dosage levels of CBD are uncertain due to a lack of human studies. Chronic high doses of up to 1500 mg per day are well tolerated and produce no noticeable physiological effects. However, there is evidence to suggest that the medical benefits of CBD disappear when dosages become excessive. For inhaled medical use, most users prefer varieties with THC:CBD ratios between 2:1 and 1:2. Extremely low-THC varieties are useful for making CBD extracts and tinctures. Unlike THC, CBD does not show up positive on standard drug tests for marijuana.
The best explanation of what full spectrum cbd cannibidiol oil is, is explained on this video, quick and easy.